Cytotoxic and HDAC inhibition IC50s (μM) of compounds 1-5 and vorinostat against human colon cancer (HCT116), human cervical (HeLa), lung (A549) and ovarian cancer (A2780) cell lines. Here, HDAC9 is linked to malignant colon neoplasm.